The Influence of Venous Tourniquet on Whole Blood Coagulation as Assessed by Thrombelastography (TEG)

Not Applicable

Recruiting

• Conditions: Disorders of coagulation; Anaesthesiology - Anaesthetics; Blood - Clotting disorders

• Registration Number: ACTRN12609000187246
• Lead Sponsor: Royal Perth Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2009-04-17
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Healthy volunteers

Exclusion Criteria

1. Prescription of any antiplatelet medication
2. Confirmed coagulation disorder (pathological or drug induced)
3. Confirmed systemic Inflammatory diseases
4. known pregnancy

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Maximum clot strength as assessed by the thromboelastography (TEG) variable 'Maximum amplitude'[The Maximum amplitude (TEG value) time point is variable between patients and is not fixed.];Fibrinolysis, as assessed by thromboelastography and identified by the Lysis 30 and Lysis 60 variables.[The Lysis 30 and Lysis 60 (TEG values) time points are variable between patients and are not therefore fixed.]

Secondary Outcome Measures

Name	Time	Method
Initiation of clotting as assessed by thromboelastography and identified by the Reaction - time (R-time) variable.[The Reaction - time (R-time) time point is variable between patients and is not therefore fixed.]